Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Tobacco Induced Diseases
Published in: Tobacco Induced Diseases 1/2014

Open Access 01-06-2014 | Meeting abstract

Design and implementation of questionnaires to assess chronic exposure to secondhand smoke in children and adults

Authors: Mary Misailidi, Christos I Papakonstantinou, Manolis N Tzatzarakis, Mathaios P Kavvalakis, Yiannis Koutedakis, Aristidis M Tsatsakis, Andreas D Flouris

Published in: Tobacco Induced Diseases | Special Issue 1/2014

Login to get access

Excerpt

Despite a multitude of anti-smoking campaigns being active worldwide, the number of smokers is currently larger than at any other time in human history. An essential first step towards minimizing the health effects of secondhand smoke (SHS) is to accurately assess the exposure level of individuals. The objectives of this study were to: (i) to develop questionnaires that can identify never-smoking children and adults experiencing increased exposure to secondhand smoke (SHS+), (ii) to determine their validity against hair nicotine, and (iii) assess their reliability. …
Metadata
Title
Design and implementation of questionnaires to assess chronic exposure to secondhand smoke in children and adults
Authors
Mary Misailidi
Christos I Papakonstantinou
Manolis N Tzatzarakis
Mathaios P Kavvalakis
Yiannis Koutedakis
Aristidis M Tsatsakis
Andreas D Flouris
Publication date
01-06-2014
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue Special Issue 1/2014
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/1617-9625-12-S1-A28

Other articles of this Special Issue 1/2014

Tobacco Induced Diseases 1/2014 Go to the issue

Introduction

Education for a tobacco free world: the 11th meeting of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID)

Meeting abstract

The importance of early COPD diagnosis during a smoking cessation program

Meeting abstract

Effects of a natural polyphenol on nicotine -induced pancreatic cancer cell proliferation

Meeting abstract

E- Cigarette acute effect on symptoms and airway inflammation: comparison of nicotine with a non-nicotine cigarette

Meeting abstract

Prevalence and determinants of SHS exposure in public and private areas after the 2010 smoke-free legislation in Greece

Meeting abstract

Comparing smoking habits and tobacco-related education between Canadian and Greek medical students
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits